Understanding the role of the immune system in fatigue22 July 2020
Versus Arthritis and the The Kennedy Trust for Rheumatology Research are jointly funding research by King’s College London to better understand the role of the immune system in post-viral fatigue experienced by people who have had COVID-19.
The work is being led by Professor Frances Williams at the Department of Twin research and Professor Carmine M. Pariante at the Institute of Psychiatry, Psychology and Neurology.
Understanding fatigue is vital to develop future treatments
We know that fatigue has a huge impact on people’s quality of life, but it’s not known what causes it, or why it can affect some people more than others.
One of the challenges in understanding the role of the immune system in people who have developed fatigue as part of their condition, is that researchers do not normally know what the system was like before they developed the condition (and fatigue).
This means it’s hard to look for differences that might cause fatigue or make people more prone to developing it.
Our ambition is to learn from the insights of this research to help improve the management of fatigue for people with arthritis.
What can we learn from COVID-19 about fatigue?
Fatigue is being seen as a common side effect of COVID-19 and some people are experiencing this symptom for a prolonged period after having the virus. Due to the widespread nature of this virus, there’s now an opportunity to be able to get a large amount of data from people who have been infected.
Researchers will be able to see any changes that have happened in these people following COVID-19 infection, and see if there are any indicators of who is more prone to developing fatigue. As well as developing an understanding of how a person’s immune function can affect the severity and persistence of fatigue.
How researchers will learn from data
Over the coming 18 months, researchers will collect data from groups of people who have already had their immune systems studied, including twins from the TwinsUK study.
Cases of the virus and controls will be identified from people using the King’s COVID-19 Symptom Tracker App which is already being used by people in the TwinsUK study. The app collects information on self-reported and tested COVID-19 cases as well as basic demographics and health information.
The researchers will analyse existing and follow up data from these people to better understand the factors which could mean some people are more likely to experience fatigue.
Achieving more together
Our partnership with The Kennedy Trust is an excellent example of how working with others can maximise the impact of research funding and allow us to achieve more than we could do on our own.
We’ll keep you posted on progress and updates, find out more about our research.
We’re here for you
If you’re feeling isolated from family and friends during these uncertain times, we’re here for you.
- If you would like to talk to someone, you can call our free helpline on 0800 5200 520 (Monday to Friday, 9am to 6pm)
- Chat to COVA, our COVID-19 Virtual Assistant, using the purple icon in the bottom right corner of this page.
- Join our online community
- Stay in touch and follow us on Twitter, Facebook and Instagram.
You might also be interested in...
The discovery of a new joint cell offers hope for people with rheumatoid arthritis
Researchers have now found a key to developing new treatments to cure the pain of rheumatoid arthritis in the joints of people with the condition who are in long-term remission.
How has research changed in response to COVID-19?
We’ve been blown away by the resilience and adaptability of our research community during this time and have would like to share some updates on how our researchers are doing.
How can studying the immune system help arthritis treatments in the future?
Understanding more about the immune system and conditions such as Lupus, psoriatic arthritis and rheumatoid arthritis will help us to develop more effective treatments in the future.